Liver Neoplasms D008113

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Liver Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Liver Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Liver Neoplasms

Description

Tumors or cancer of the LIVER.   MeSH

Subtype Terms (3)

Adenoma, Liver Cell
2 drugs (1 approved, 1 experimental)

Carcinoma, Hepatocellular
570 drugs (183 approved, 387 experimental)

Liver Neoplasms, Experimental
2 drugs (1 approved, 1 experimental)


Phase 2 Indicated Drugs (137)

Phase 1 Indicated Drugs (82)


Organization Involved with Phase 3 Indications (68)

Organization Involved with Phase 2 Indications (167)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.